Cardiotoxicity in patients treated with bevacizumab is potentially reversible

Eliza A. Hawkes; Alicia F.C. Okines; Chris Plummer; David Cunningham

doi:10.1200/JCO.2011.35.5008

Cardiotoxicity in patients treated with bevacizumab is potentially reversible

Eliza A. Hawkes
, Alicia F.C. Okines
, Chris Plummer
, David Cunningham

Research output: Contribution to journal › Letter › Other › peer-review

Original language	English
Pages (from-to)	e560-e562
Number of pages	3
Journal	Journal of Clinical Oncology
Volume	29
Issue number	18
DOIs	https://doi.org/10.1200/JCO.2011.35.5008
Publication status	Published - 20 Jun 2011
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1200/JCO.2011.35.5008

Cite this

@article{18e42fb2d53f4f47a8bec85cdc3404be,

title = "Cardiotoxicity in patients treated with bevacizumab is potentially reversible",

author = "Hawkes, \{Eliza A.\} and Okines, \{Alicia F.C.\} and Chris Plummer and David Cunningham",

year = "2011",

month = jun,

day = "20",

doi = "10.1200/JCO.2011.35.5008",

language = "English",

volume = "29",

pages = "e560--e562",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology ",

number = "18",

}

TY - JOUR

T1 - Cardiotoxicity in patients treated with bevacizumab is potentially reversible

AU - Hawkes, Eliza A.

AU - Okines, Alicia F.C.

AU - Plummer, Chris

AU - Cunningham, David

PY - 2011/6/20

Y1 - 2011/6/20

UR - https://www.scopus.com/pages/publications/79959296552

U2 - 10.1200/JCO.2011.35.5008

DO - 10.1200/JCO.2011.35.5008

M3 - Letter

C2 - 21606423

AN - SCOPUS:79959296552

SN - 0732-183X

VL - 29

SP - e560-e562

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 18

ER -

Cardiotoxicity in patients treated with bevacizumab is potentially reversible

UN SDGs

Access to Document

Other files and links

Cite this